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Inadvertent doping through the use of nutritional supplements
is a potentially important cause of the increase in positive
doping cases among high-profile Olympic athletes. There are a
wide variety of nutritional substances on the market
specifically designed for athletes. These supplements are
promoted among athletes for their performance-enhancing
properties, and for faster recovery during training,
manipulation of body composition and reduction in illness and
infection risks. Athletes assume that these supplements do not
contain prohibited substances because they are readily
available without prescription and are sold legally as
supplements.
In many countries the manufacture of nutritional
supplements is not regulated appropriately. This means that
the ingredients of the supplement may not match those listed
on the label of the container. Other problems associated with
this lack of regulation are batch composition differences and
possible contamination with prohormones, which are
prohibited substances in sport. Recent studies
1
have shown that
non-hormonal nutritional supplements such as vitamins,
minerals and amino acids may contain undeclared substances
not listed on the label. In some cases the undeclared substances
found in the supplement can include those prohibited by the
Anti-Doping Code of the International Olympic Committee
(IOC) and the World Anti-Doping Agency (WADA).
Results from an IOC study2 on nutritional supplements (13
countries excluding South Africa) showed that 94 of 634
samples (14.8%) contained prohormones not listed on the label.
Both Catlin et al.3 and Kamber et al.4 analysed nutritional
supplements and found hormone contaminants not listed on
the labels. Results from our previous study on nutritional
supplements available on the South African market showed
that approximately 7% of supplements tested could be
mislabelled or contaminated with prohibited substances.5 The
results of the effect of contaminated nutritional supplement
ingestion may be useful to clinicians working in this field.
The aim of this study was to determine if the intake of a
nutritional supplement containing microgram amounts of
prohibited substances could cause an athlete to fail a dope test.
Materials and methods
Contaminated supplements were identified in an ongoing
study that screened over-the-counter nutritional supplements.
Five healthy male volunteers (age 24 - 55 years, weight 77 - 99.4
kg) received 1 capsule of a nutritional supplement that was
contaminated with 19-nor-4-androstenedione and 4-
androstenedione (previously determined as 8.4 - 31.8
µg/capsule for 19-nor-4-androstenedione and 0.1 - 0.4
µg/capsule for 4-androstenedione).
5
Urine samples were
collected before administration and at 2, 4, 8, 12, 24, 30, 36 and
48 hours post administration. Urine samples were refrigerated
after collection pending analysis. The samples were analysed
using gas chromatography/mass spectrometry (GC/MS) for
the glucuronides of 19-norandrosterone, testosterone and
epitestosterone according to the screening procedure for
anabolic steroids.
6
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were quantified by GC/MS using a calibration curve. The
samples were analysed in duplicate.
The study was approved by the Ethics Committee for
Medical Research of the University of the Free State. The
volunteers were informed of the low amounts of prohormones
in the product, and written consent was obtained.
Results
Fig. 1 shows the urinary concentrations of 19-norandrosterone
(the main metabolite detected in urine after the intake of 19-
nor-4-androstenedione) in the volunteers after the
administration of the contaminated supplement. The highest
concentration of 19-norandrosterone found in the samples was
54.6 ng/ml.  The peak concentrations of 19-norandrosterone
varied between 11 ng/ml and 55 ng/ml.  The urinary
concentration of 19-norandrosterone in 1 volunteer dropped
below the threshold level between 8 and 12 hours post
administration. In 2 volunteers, 19-norandrosterone above the
threshold level could still be detected for longer than 36 hours
post administration.
Discussion
Several studies have shown that nutritional supplements can
be contaminated with prohormones, and the supplements
available in South Africa are no exception.
5
The quantity of
prohormone in the supplement was lower than the amount
found in commercially available prohormone supplements. The
contaminated nutritional supplement was administered to 5
male volunteers to determine if the ingestion of these small
amounts of 19-nor-4-androstenedione (0.02 - 0.06% of the usual
dose of 50 mg) would lead to a positive dope test. All the
volunteers showed concentrations above the WADA threshold
of 2 ng/ml from 2 hours post administration. 
The exact dosage of 19-nor-4-androstenedione administered
to the volunteers was unknown because of the variation in
concentration of 19-nor-4-androstenedione in the capsules.
5
These results were obtained after the ingestion of only 1
capsule. However, the recommended dosage according to the
manufacturer is 4 capsules 3 times a day, which can result in
even higher concentrations of 19-norandrosterone and for
longer time periods. The results are similar to those obtained
by Geyer et al.
2
where the administration of nutritional
supplements containing different amounts of 19-nor-4-
androstenedione (0.8 - 24.6 µg/capsule) also led to positive
doping tests 2 hours post administration. According to Geyer 
et al.
2
it can be estimated that nutritional supplements
containing nandrolone prohormones in concentrations higher
than 1 µg may result in a positive dope test. However,
supplements with smaller concentrations of nandrolone
prohormones could still lead to a positive test depending on
the recommended dosage of the manufacturer.
The use of testosterone and its prohormones, like DHEA and
4-androstenedione, lead to an increase in the urinary
testosterone/epitestosterone ratio. No increase in the
testosterone/epitestosterone ratio was observed in any of the
urine samples in this study and therefore none of the
volunteers tested positive for 4-androstenedione.  This could be
because of the low concentration of 4-androstenedione in the
capsules, which ranged from 0.1 to 0.4 µg/capsule.
5
Conclusion
The intake of microgram amounts of prohibited substances in
contaminated supplements can cause an athlete to fail a dope
test. Our results are of particular interest to team physicians
and other clinicians prescribing supplements to competitors in
sport. Athletes taking nutritional supplements should take
them with the full knowledge and acceptance of WADA’s strict
liability rule, which states that an athlete is ultimately
responsible for substances found in his/her body fluids
irrespective of their origin. There is no guarantee that taking a
nutritional supplement will not result in a positive dope case,
as shown in this study.
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Fig. 1. Urinary concentrations of 19-norandrosterone in 5 male
volunteers after administration of a contaminated nutritional
supplement.
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